Related Experiment Video
Updated: Feb 6, 2026

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells
Published on: October 1, 2010
Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5
Laura F Wetherill1, Christopher W Wasson2, Gemma Swinscoe2
1School of Molecular and Cellular Biology, Faculty of Biological Sciences, UK; School of Medicine, Faculty of Medicine & Health, University of Leeds, Wellcome Trust Brenner Building, St James' University Hospital, Beckett St., Leeds, LS9 7TF, UK; Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.
Abstract:
Despite the availability of prophylactic vaccines the burden of human papillomavirus (HPV) associated malignancy remains high and there is a need to develop additional therapeutic strategies to complement vaccination. We have previously shown that the poorly characterised E5 oncoprotein forms a virus-coded ion channel or viroporin that was sensitive to the amantadine derivative rimantadine. We now demonstrate that alkylated imino sugars, which have antiviral activity against a number of viruses, inhibit E5 channel activity in vitro. Using molecular modelling we predict that imino sugars intercalate between E5 protomers to prevent channel oligomerisation. We explored the ability of these viroporin inhibitors to block E5-mediated activation of mitogenic signalling in keratinocytes. Treatment with either rimantadine or imino sugars prevented ERK-MAPK phosphorylation and reduced cyclin B1 expression in cells expressing E5 from a number of high-risk HPV types. Moreover, viroporin inhibitors also reduced ERK-MAPK activation and cyclin B1 expression in differentiating primary human keratinocytes containing high-risk HPV18. These observations provide evidence of a key role for E5 viroporin function during the HPV life cycle. Viroporin inhibitors could be utilised for stratified treatment of HPV associated tumours prior to virus integration, or as true antiviral therapies to eliminate virus prior to malignant transformation.
Insights
New antiviral therapies targeting the human papillomavirus (HPV) E5 oncoprotein show promise. Imino sugars and rimantadine inhibit E5 viroporin activity, blocking cancer-driving signaling pathways.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human papillomavirus (HPV) infection is a major cause of cancer, and current vaccines do not offer complete protection.
- The HPV E5 oncoprotein forms a viroporin channel, a potential therapeutic target.
- Previous work identified rimantadine as an inhibitor of the E5 ion channel.
Purpose of the Study:
- To investigate the antiviral potential of imino sugars against HPV E5 viroporin.
- To explore the mechanism of imino sugar inhibition of E5 channel activity.
- To evaluate the efficacy of viroporin inhibitors in blocking HPV-mediated oncogenic signaling.
Main Methods:
- In vitro inhibition assays of E5 channel activity by imino sugars.
- Molecular modeling to predict imino sugar-E5 interaction.
- Assessment of ERK-MAPK phosphorylation and cyclin B1 expression in HPV-infected keratinocytes treated with inhibitors.
Main Results:
- Alkylated imino sugars inhibited E5 viroporin channel activity in vitro.
- Molecular modeling suggested imino sugars disrupt E5 protomer oligomerization.
- Rimantadine and imino sugars reduced ERK-MAPK phosphorylation and cyclin B1 expression in keratinocytes expressing high-risk HPV E5.
- Viroporin inhibitors demonstrated efficacy in primary human keratinocytes infected with HPV18.
Conclusions:
- The HPV E5 oncoprotein functions as a viroporin critical for the viral life cycle.
- Viroporin inhibitors, including imino sugars and rimantadine, represent a potential therapeutic strategy for HPV-associated malignancies.
- These inhibitors could be used for stratified treatment of tumors or as antiviral agents to prevent malignant transformation.
More Related Videos
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
α-Alkylation of Ketones via Enolate Ions
Mechanically-gated Ion Channels
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
G-Protein Gated Ion Channels
Sensory...